Graft-versus-host disease: the viewpoint from the donor T cell.
Chao
N J
NJ
Duke University Medical Center, Durham, NC 27710, USA. chao0002@mc.duke.edu
D000818:Animals; D017951:Antigen Presentation; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D003602:Cytotoxicity, Immunologic; D006086:Graft vs Host Disease / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D006649:Histocompatibility Antigens / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008213:Lymphocyte Activation; D051379:Mice; D010455:Peptides / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell / Q000502:physiology; D018089:Superantigens / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000473:pathology / Q000637:transplantation
D015815:Cell Adhesion Molecules; D016207:Cytokines; D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D010455:Peptides; D011948:Receptors, Antigen, T-Cell; D018089:Superantigens; C021759:(T,G)-A-L